Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 19/20 | 0.52 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.52 |
| ▸ | HSP90AB1 | P08238 | 18/20 | 0.45 |
| ▸ | TRAP1 | Q12931 | 2/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 4/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.35 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31146872 | 0.86 | HSP90AA1 (0.43) | HSP90AA1HSP90B1HSP90AB1TRAP1ERBB2 | |
| SCHEMBL31146875 | 0.86 | HSP90AA1 (0.43) | HSP90AA1HSP90B1HSP90AB1TRAP1ERBB2 | |
| SCHEMBL14067096 | 0.85 | HSP90AA1 (0.43) | HSP90AA1HSP90B1HSP90AB1TRAP1ERBB2 | |
| SCHEMBL4903368 | 0.83 | HSP90AA1 (0.50) | HSP90AA1HSP90B1HSP90AB1TRAP1ERBB2 | |
| SCHEMBL3122649 | 0.83 | HSP90AB1 (0.50) | HSP90AA1HSP90B1HSP90AB1TRAP1ERBB2 | |
| SCHEMBL1858420 | 0.83 | HSP90AA1 (0.50) | HSP90AA1HSP90AB1ERBB2HDAC3HDAC4 | |
| SCHEMBL13845812 | 0.83 | HSP90AB1 (0.37) | HSP90AA1HSP90B1HSP90AB1TRAP1ERBB2 | |
| SCHEMBL30599262 | 0.83 | HSP90AB1 (0.50) | HSP90AA1HSP90B1HSP90AB1TRAP1ERBB2 | |
| SCHEMBL2441832 | 0.83 | HSP90AA1 (0.52) | HSP90AA1HSP90B1HSP90AB1TRAP1 | |
| SCHEMBL3127736 | 0.81 | HSP90AA1 (0.40) | HSP90AA1HSP90B1HSP90AB1TRAP1ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3091019-B1 | PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS | SLOAN KETTERING INST CANCER RES (US) | 2019-04-03 | — | — | EP | disclosed |
| US-10172863-B2 | Purine derivatives useful as HSP90 inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2019-01-08 | — | — | US | disclosed |
| US-10064867-B2 | Hsp90 inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2018-09-04 | — | — | US | disclosed |
| US-9926321-B2 | Hsp90 inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2018-03-27 | — | — | US | disclosed |
| US-9926321-B2 | Hsp90 inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2018-03-27 | — | — | US | disclosed |
| EP-2694506-B1 | HSP90 INHIBITORS | SLOAN-KETTERING INST FOR CANCER RES (US) | 2017-09-20 | — | — | EP | disclosed |
| EP-2694506-B1 | HSP90 INHIBITORS | SLOAN-KETTERING INST FOR CANCER RES (US) | 2017-09-20 | — | — | EP | disclosed |
| US-20170151247-A1 | HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2017-06-01 | — | — | US | disclosed |
| US-20170151247-A1 | HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2017-06-01 | — | — | US | disclosed |
| US-20170151247-A1 | HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2017-06-01 | — | — | US | disclosed |
| US-20140045867-A1 | HSP90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2014-02-13 | — | — | US | disclosed |
| US-20140045867-A1 | HSP90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2014-02-13 | — | — | US | disclosed |
| US-20140045867-A1 | HSP90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2014-02-13 | — | — | US | disclosed |
| EP-2694506-A1 | HSP90 INHIBITORS | Sloan-kettering Institute For Cancer Research (US) | 2014-02-12 | — | — | EP | disclosed |
| WO-2012138894-A1 | HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-10-11 | — | — | WO | disclosed |
| WO-2012138896-A1 | HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-10-11 | — | — | WO | disclosed |
| WO-2012138896-A1 | HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120208806-A1 | Hsp90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-08-16 | — | — | US | disclosed |
| US-20120208806-A1 | Hsp90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-08-16 | — | — | US | disclosed |
| WO-2011044394-A1 | PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2011-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170151247-A1 | HSP90 INHIBITORS | HSP90AB1, HSP90B1, HSP90AA1 | HSP90AA1 3/4885HSP90B1 2/4885HSP90AB1 1/4885 |
| US-10172863-B2 | Purine derivatives useful as HSP90 inhibitors | XDH, HSP90B1, HSP90AA1 | HSP90AA1 3/4885HSP90B1 2/4885HSP90AB1 4/4885 |
| US-20140045867-A1 | HSP90 Inhibitors | HSP90AB1, HSP90B1, HSP90AA1 | HSP90AA1 3/4885HSP90B1 2/4885HSP90AB1 1/4885 |
| US-20120208806-A1 | Hsp90 Inhibitors | HSP90B1, HSP90AB1, HSP90AB2P | HSP90AA1 4/4885HSP90B1 1/4885HSP90AB1 2/4885 |
| US-10064867-B2 | Hsp90 inhibitors | HSP90AB1, HSP90B1, HSP90AA1 | HSP90AA1 3/4885HSP90B1 2/4885HSP90AB1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.